These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27322337)

  • 1. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma.
    Diab M; Muqbil I; Mohammad RM; Azmi AS; Philip PA
    J Clin Med; 2016 Jun; 5(6):. PubMed ID: 27322337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.
    Ren L; Yu Y
    Ther Clin Risk Manag; 2018; 14():179-187. PubMed ID: 29416345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.
    Tesfaye AA; Azmi AS; Philip PA
    Am J Pathol; 2019 Jan; 189(1):58-70. PubMed ID: 30558723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs.
    Mortoglou M; Manić L; Buha Djordjevic A; Bulat Z; Đorđević V; Manis K; Valle E; York L; Wallace D; Uysal-Onganer P
    Toxics; 2022 Mar; 10(3):. PubMed ID: 35324773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.
    Ta N; Huang X; Zheng K; Zhang Y; Gao Y; Deng L; Zhang B; Jiang H; Zheng J
    Cell Physiol Biochem; 2018; 51(2):711-728. PubMed ID: 30463064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Cancer Stem Cells and Therapeutic Approaches.
    Ercan G; Karlitepe A; Ozpolat B
    Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.
    Hernandez YG; Lucas AL
    World J Gastrointest Oncol; 2016 Jan; 8(1):18-29. PubMed ID: 26798434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.
    Passadouro M; Faneca H
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer.
    Qadir MI; Faheem A
    Crit Rev Eukaryot Gene Expr; 2017; 27(3):197-204. PubMed ID: 29199604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.